C/CLP Antagonists and Methods of Use Thereof

The invention relates to the novel discovery that antagonizing a C/CLP can be useful for the treatment of diseases associated with the upregulation of one or more C/CLP such as Th2-driven and/or IL-13 mediated inflammatory diseases. Accordingly the present invention provides C/CLP antagonists and also provides compositions and methods for the prevention, management, treatment or amelioration of an inflammatory condition associated with the upregulation of a C/CLP or one or more symptoms thereof and/or the inhibition of IL-13 mediated inflammation.

Attached files:


Patents:
US 20,110,059,100

Inventor(s): REED JENNIFER L [US]; WHITE WENDY I [US]; COYLE ANTHONY [US]; KOZHICH ALEXANDER [US]; ELIAS JACK [US]; DONACKI NANCI [US]; GAO C

Type of Offer: Sale



« More Medical Patents

---